Oceania Healthcare Future Growth
Future criteria checks 4/6
Oceania Healthcare is forecast to grow earnings and revenue by 66.9% and 7.9% per annum respectively. EPS is expected to grow by 66.8% per annum. Return on equity is forecast to be 6.9% in 3 years.
Key information
66.9%
Earnings growth rate
66.8%
EPS growth rate
Healthcare earnings growth | 14.2% |
Revenue growth rate | 7.9% |
Future return on equity | 6.9% |
Analyst coverage | Low |
Last updated | 16 Dec 2024 |
Recent future growth updates
Recent updates
Estimating The Intrinsic Value Of Oceania Healthcare Limited (NZSE:OCA)
Nov 26Oceania Healthcare Limited (NZSE:OCA) Stock Rockets 31% But Many Are Still Ignoring The Company
Jul 22Oceania Healthcare Limited's (NZSE:OCA) CEO Might Not Expect Shareholders To Be So Generous This Year
Jun 20Oceania Healthcare's (NZSE:OCA) Earnings Are Of Questionable Quality
May 31Be Wary Of Oceania Healthcare (NZSE:OCA) And Its Returns On Capital
May 18Calculating The Fair Value Of Oceania Healthcare Limited (NZSE:OCA)
Feb 22Oceania Healthcare (NZSE:OCA) Is Paying Out Less In Dividends Than Last Year
Nov 26Oceania Healthcare Limited's (NZSE:OCA) Intrinsic Value Is Potentially 75% Above Its Share Price
Aug 02Oceania Healthcare (NZSE:OCA) Is Paying Out A Larger Dividend Than Last Year
May 23Calculating The Intrinsic Value Of Oceania Healthcare Limited (NZSE:OCA)
Jan 24Factors Income Investors Should Consider Before Adding Oceania Healthcare Limited (NZSE:OCA) To Their Portfolio
May 04Oceania Healthcare Limited's (NZSE:OCA) Intrinsic Value Is Potentially 50% Above Its Share Price
Mar 23Does Oceania Healthcare (NZSE:OCA) Have A Healthy Balance Sheet?
Feb 25It Might Not Be A Great Idea To Buy Oceania Healthcare Limited (NZSE:OCA) For Its Next Dividend
Feb 04If You Had Bought Oceania Healthcare (NZSE:OCA) Shares Three Years Ago You'd Have Earned 39% Returns
Jan 17Read This Before Buying Oceania Healthcare Limited (NZSE:OCA) For Its Dividend
Dec 27Is There An Opportunity With Oceania Healthcare Limited's (NZSE:OCA) 32% Undervaluation?
Nov 30Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 332 | 79 | N/A | N/A | 3 |
3/31/2026 | 312 | 62 | N/A | N/A | 3 |
3/31/2025 | 297 | 45 | N/A | N/A | 3 |
9/30/2024 | 267 | -21 | 40 | 99 | N/A |
6/30/2024 | 266 | 5 | 36 | 92 | N/A |
3/31/2024 | 265 | 31 | 32 | 85 | N/A |
12/31/2023 | 264 | 35 | 77 | 95 | N/A |
9/30/2023 | 260 | 39 | 112 | 96 | N/A |
6/30/2023 | 254 | 27 | 63 | 83 | N/A |
3/31/2023 | 247 | 15 | 14 | 70 | N/A |
12/31/2022 | 243 | 25 | 14 | 77 | N/A |
9/30/2022 | 238 | 35 | 13 | 84 | N/A |
6/30/2022 | 235 | 48 | 31 | 95 | N/A |
3/31/2022 | 231 | 61 | 49 | 106 | N/A |
3/31/2021 | 213 | 103 | 72 | 115 | N/A |
11/30/2020 | 203 | -4 | 80 | 117 | N/A |
8/31/2020 | 200 | -9 | 69 | 108 | N/A |
5/31/2020 | 196 | -14 | 59 | 99 | N/A |
2/29/2020 | 193 | 23 | 51 | 99 | N/A |
11/30/2019 | 191 | 59 | 43 | 99 | N/A |
8/31/2019 | 190 | 52 | 30 | 94 | N/A |
5/31/2019 | 189 | 45 | 16 | 89 | N/A |
2/28/2019 | 189 | 41 | 34 | 101 | N/A |
11/30/2018 | 188 | 36 | 52 | 112 | N/A |
8/31/2018 | 186 | 56 | N/A | 97 | N/A |
5/31/2018 | 184 | 77 | N/A | 82 | N/A |
2/28/2018 | 180 | 71 | N/A | 63 | N/A |
11/30/2017 | 176 | 65 | N/A | 43 | N/A |
8/31/2017 | 175 | 55 | N/A | 41 | N/A |
5/31/2017 | 174 | 45 | N/A | 39 | N/A |
5/31/2016 | 173 | 49 | N/A | 40 | N/A |
5/31/2015 | 171 | 19 | N/A | 30 | N/A |
5/31/2014 | 173 | -31 | N/A | 33 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OCA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3%).
Earnings vs Market: OCA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: OCA is expected to become profitable in the next 3 years.
Revenue vs Market: OCA's revenue (7.9% per year) is forecast to grow faster than the NZ market (4.4% per year).
High Growth Revenue: OCA's revenue (7.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OCA's Return on Equity is forecast to be low in 3 years time (6.9%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/08 10:35 |
End of Day Share Price | 2025/02/07 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Oceania Healthcare Limited is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Stephen Ridgewell | Deutsche Bank |
Aaron Ibbotson | Forsyth Barr Group Ltd. |
Arie Dekker | Jarden Limited |